ECONOPRED

LOE Approaching

prednisolone acetate

NDAOPHTHALMICSUSPENSION/DROPS
Approved
Jul 1973
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
6

Mechanism of Action

CLINICAL PHARMACOLOGY Corticosteroids inhibit the inflammatory response to a variety of inciting agents and probably delay or slow healing. They inhibit the edema, fibrin deposition, capillary dilation, leukocyte migration, capillary proliferation, fibroblast proliferation, deposition of collagen,…

Clinical Trials (5)

NCT01384266N/ACompleted

A Comparison of 0.5% Loteprednol Etabonate Versus 1% Prednisolone Acetate Following Cataract Surgery

Started May 2010
90 enrolled
Intraocular Inflammation
NCT01244334Phase 4Completed

Study of Difluprednate vs. Prednisolone Acetate on Visual Acuity, and Corneal Edema Following Cataract Surgery.

Started Mar 2009
52 enrolled
CataractsCorneal EdemaRetinal Structural Change, Deposit and Degeneration+1 more
NCT00198523Phase 3Completed

A Bioequivalence Study of Tobramycin and Prednisolone Acetate Compared to PredForte

Started Jul 2005
132 enrolled
Eye InfectionsPostoperative Complications
NCT00139295Phase 3Completed

Comparison of Hylastan to Methylprednisolone Acetate in Patients With Symptomatic Osteoarthritis of the Knee

Started Oct 2004
Osteoarthritis, Knee
NCT00170729Phase 4Completed

A Study to Compare Ocular Safety and Tolerability of Eye Drops Containing Prednisolone Acetate in Patients With Intraocular Inflammation After Cataract Surgery

Started Aug 2004
62 enrolled
Cataract Surgery
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers